A Risk-Adapted Protocol of Prophylactic Zoledronic Acid Prevents Bone Mineral Density Loss Post Allograft: Results of the ALLG Bm07 Phase II Prospective Trial
Authors:
- Eric WongEWEric Wong
- Belinda ButcherBBBelinda Butcher
- Bereha KhodrBKBereha Khodr
- Ashish BajelABAshish Bajel
- Mark HertzbergMHMark Hertzberg
- Sushrut PatilSPSushrut Patil
- Alwyn D'SOuzaADAlwyn D'SOuza
- Peter GanleyPGPeter Ganley
- Peter EbelingPEPeter Ebeling
- Andrew GriggAGAndrew Grigg
Open Access
- 1 March 2017
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (3) , S68-S69